Skip to main content

Rezzayo Side Effects

Generic name: rezafungin

Medically reviewed by Drugs.com. Last updated on Dec 29, 2023.

Note: This document contains side effect information about rezafungin. Some dosage forms listed on this page may not apply to the brand name Rezzayo.

Applies to rezafungin: intravenous powder for solution.

Serious side effects of Rezzayo

Along with its needed effects, rezafungin (the active ingredient contained in Rezzayo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking rezafungin:

More common

Less common

Incidence not known

Other side effects of Rezzayo

Some side effects of rezafungin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to rezafungin: intravenous powder for injection.

General

The most common adverse reactions occurring in 5% of patients or greater included hypokalemia, pyrexia, diarrhea, anemia, vomiting, nausea, hypomagnesemia, abdominal pain, constipation, and hypophosphatemia.[Ref]

Dermatologic

Common (less than 5%): Erythema[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (11%)

Common (1% to 10%): Vomiting, nausea, abdominal pain, constipation

Reported as less than 5%: Dysphagia, gastrointestinal hemorrhage[Ref]

Hematologic

Very common (10% or more): Anemia (10%)

Common (less than 5%): Disseminated intravascular coagulation[Ref]

Local

Common (less than 5%): Infusion-related reactions (including flushing, sensation of warmth, urticaria, nausea, and chest tightness)[Ref]

Metabolic

Very common (10% or more): Hypokalemia (15%),

Common (1% to 10%): Hypomagnesemia, hypophosphatemia, fluid overload (less than 5%)[Ref]

Other

Very common (10% or more): Pyrexia (12%)[Ref]

Psychiatric

Common (less than 5%): Insomnia[Ref]

Renal

Common (less than 5%): Acute kidney injury[Ref]

Hepatic

Common (less than 5%): Abnormal liver tests (including hypertransaminasemia and increased gamma-glutamyltransferase)[Ref]

Nervous system

Common (less than 5%): Headache, dizziness, peripheral neuropathy (including neuropathy

peripheral, polyneuropathy, and peroneal nerve palsy), tremors (occurring in second or third weeks of treatment)[Ref]

References

1. Product Information. Rezzayo (rezafungin). Melinta Therapeutics, Inc. 2023.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.